Bridgebio Stock Market Value


USD 8.84  0.14  1.61%   

Bridgebio Pharma's market value is the price at which a share of Bridgebio Pharma stock trades on a public exchange. It measures the collective expectations of Bridgebio Pharma investors about the entity's future performance. With this module, you can estimate the performance of a buy and hold strategy of Bridgebio Pharma and determine expected loss or profit from investing in Bridgebio Pharma over a given investment horizon. Continue to Bridgebio Pharma Hype Analysis, Bridgebio Pharma Correlation, Bridgebio Pharma Valuation, Bridgebio Pharma Volatility, as well as analyze Bridgebio Pharma Alpha and Beta and Bridgebio Pharma Performance.

Is Bridgebio Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bridgebio Pharma. If investors know Bridgebio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bridgebio Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Bridgebio Pharma is measured differently than its book value, which is the value of Bridgebio that is recorded on the company's balance sheet. Investors also form their own opinion of Bridgebio Pharma's value that differs from its market value or its book value, called intrinsic value, which is Bridgebio Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bridgebio Pharma's market value can be influenced by many factors that don't directly affect Bridgebio Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bridgebio Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Bridgebio Pharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bridgebio Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bridgebio Pharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bridgebio Pharma's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bridgebio Pharma.
No Change 0.00  0.0 
In 1 year 11 months and 22 days
If you would invest  0.00  in Bridgebio Pharma on July 9, 2020 and sell it all today you would earn a total of 0.00 from holding Bridgebio Pharma or generate 0.0% return on investment in Bridgebio Pharma over 720 days. Bridgebio Pharma is related to or competes with General Electric. BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseasesMore

Bridgebio Pharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bridgebio Pharma's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bridgebio Pharma upside and downside potential and time the market with a certain degree of confidence.

Bridgebio Pharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Bridgebio Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bridgebio Pharma's standard deviation. In reality, there are many statistical measures that can use Bridgebio Pharma historical prices to predict the future Bridgebio Pharma's volatility.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Bridgebio Pharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Bridgebio Pharma in the context of predictive analytics.
LowEstimated ValueHigh
LowReal ValueHigh
LowNext ValueHigh
8 Analysts
LowTarget PriceHigh
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Bridgebio Pharma. Your research has to be compared to or analyzed against Bridgebio Pharma's peers to derive any actionable benefits. When done correctly, Bridgebio Pharma's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Bridgebio Pharma.

Bridgebio Pharma Backtested Returns

We consider Bridgebio Pharma slightly risky. Bridgebio Pharma secures Sharpe Ratio (or Efficiency) of 0.0015, which signifies that the company had 0.0015% of return per unit of risk over the last 3 months. Our standpoint towards foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-eight technical indicators for Bridgebio Pharma, which you can use to evaluate the future volatility of the firm. Please confirm Bridgebio Pharma mean deviation of 5.58, and Risk Adjusted Performance of (0.006513) to double-check if the risk estimate we provide is consistent with the expected return of 0.0108%.
The firm shows a Beta (market volatility) of 2.5335, which signifies a somewhat significant risk relative to the market. Let's try to break down what Bridgebio's beta means in this case. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bridgebio Pharma will likely underperform. Although it is important to respect Bridgebio Pharma historical returns, it is better to be realistic regarding the information on the equity's current trending patterns. The philosophy towards foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance, including all available fundamental and technical indicators. By analyzing Bridgebio Pharma technical indicators, you can presently evaluate if the expected return of 0.0108% will be sustainable into the future. Bridgebio Pharma right now shows a risk of 7.26%. Please confirm Bridgebio Pharma jensen alpha, semi variance, day typical price, as well as the relationship between the maximum drawdown and accumulation distribution to decide if Bridgebio Pharma will be following its price patterns.



Excellent reverse predictability

Bridgebio Pharma has excellent reverse predictability. Overlapping area represents the amount of predictability between Bridgebio Pharma time series from 9th of July 2020 to 4th of July 2021 and 4th of July 2021 to 29th of June 2022. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bridgebio Pharma price movement. The serial correlation of -0.84 indicates that around 84.0% of current Bridgebio Pharma price fluctuation can be explain by its past prices.
Correlation Coefficient-0.84
Spearman Rank Test-0.65
Residual Average0.0
Price Variance414.98

Bridgebio Pharma lagged returns against current returns

Autocorrelation, which is Bridgebio Pharma stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bridgebio Pharma's stock expected returns. We can calculate the autocorrelation of Bridgebio Pharma returns to help us make a trade decision. For example, suppose you find that Bridgebio Pharma stock has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the stock movement to match the lagging time series.
 Current and Lagged Values 

Bridgebio Pharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bridgebio Pharma stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bridgebio Pharma stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bridgebio Pharma stock over time.
 Current vs Lagged Prices 

Bridgebio Pharma Lagged Returns

When evaluating Bridgebio Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bridgebio Pharma stock have on its future price. Bridgebio Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bridgebio Pharma autocorrelation shows the relationship between Bridgebio Pharma stock current value and its past values and can show if there is a momentum factor associated with investing in Bridgebio Pharma.
 Regressed Prices 

Bridgebio Pharma Investors Sentiment

The influence of Bridgebio Pharma's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Bridgebio. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Bridgebio Pharma Implied Volatility

Bridgebio Pharma's implied volatility exposes the market's sentiment of Bridgebio Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Bridgebio Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Bridgebio Pharma stock will not fluctuate a lot when Bridgebio Pharma's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Bridgebio Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Bridgebio Pharma's short interest history, or implied volatility extrapolated from Bridgebio Pharma options trading.

Current Sentiment - BBIO

Bridgebio Pharma Investor Sentiment

Macroaxis portfolio users are unresponsive in their opinion about investing in Bridgebio Pharma. What is your opinion about investing in Bridgebio Pharma? Are you bullish or bearish?
50% Bullish
50% Bearish

Pair Trading with Bridgebio Pharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bridgebio Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bridgebio Pharma will appreciate offsetting losses from the drop in the long position's value.

Bridgebio Pharma Pair Correlation

Correlation Analysis For Direct Indexing and Tax-loss Harvesting

The ability to find closely correlated positions to Bridgebio Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bridgebio Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bridgebio Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bridgebio Pharma to buy it.
The correlation of Bridgebio Pharma is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bridgebio Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bridgebio Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bridgebio Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Continue to Bridgebio Pharma Hype Analysis, Bridgebio Pharma Correlation, Bridgebio Pharma Valuation, Bridgebio Pharma Volatility, as well as analyze Bridgebio Pharma Alpha and Beta and Bridgebio Pharma Performance. Note that the Bridgebio Pharma information on this page should be used as a complementary analysis to other Bridgebio Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Bridgebio Stock analysis

When running Bridgebio Pharma price analysis, check to measure Bridgebio Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bridgebio Pharma is operating at the current time. Most of Bridgebio Pharma's value examination focuses on studying past and present price action to predict the probability of Bridgebio Pharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bridgebio Pharma's price. Additionally, you may evaluate how the addition of Bridgebio Pharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bridgebio Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bridgebio Pharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bridgebio Pharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...